BEAM Beam Therapeutics Inc.

NASDAQ

$24.27

Beam Therapeutics Inc. (BEAM) Earnings News

Earnings press releases, previews and reviews for Beam Therapeutics Inc. (BEAM), newest first.

Tuesday August 4, 2026 7:00 AM ET

Beam Therapeutics Reports Second Quarter 2026 Financial Results and Announces First Patient Dosed in Global Pivotal Cohort of BEAM-302 Trial in Alpha-1 Antitrypsin Deficiency (AATD)

Thursday May 7, 2026 7:00 AM ET

Beam Therapeutics Reports First Quarter 2026 Financial Results and Recent Business Updates